In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

BACKGROUND: The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first broke out in Wuhan (China) and subsequently spread worldwide. Chloroquine has been sporadically used in treating SARS-CoV-2 infection. Hydroxychloroquine shares the same mechanism of action as chloroquine, but its mor...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Infect Dis
Main Authors: Yao, Xueting, Ye, Fei, Zhang, Miao, Cui, Cheng, Huang, Baoying, Niu, Peihua, Liu, Xu, Zhao, Li, Dong, Erdan, Song, Chunli, Zhan, Siyan, Lu, Roujian, Li, Haiyan, Tan, Wenjie, Liu, Dongyang
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Major Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7108130/
https://ncbi.nlm.nih.gov/pubmed/32150618
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciaa237
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados